These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 25468749)
41. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Leggett MD; Chen SL; Schneider PD; Martinez SR Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930 [TBL] [Abstract][Full Text] [Related]
42. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation]. Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486 [TBL] [Abstract][Full Text] [Related]
43. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522 [TBL] [Abstract][Full Text] [Related]
44. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer. Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565 [TBL] [Abstract][Full Text] [Related]
45. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study. Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525 [TBL] [Abstract][Full Text] [Related]
46. Disparities between male and female patients with thyroid cancers: sex difference or gender divide? Machens A; Hauptmann S; Dralle H Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243 [TBL] [Abstract][Full Text] [Related]
47. Lymph node characteristics for predicting locoregional recurrence of papillary thyroid cancer in adolescents and young adults. Sun Y; Liu X; Ouyang W; Feng H; Wu J; Chen P; Wang J Oral Oncol; 2017 Mar; 66():22-27. PubMed ID: 28249644 [TBL] [Abstract][Full Text] [Related]
48. An analysis of factors predicting lateral cervical nodal metastases in papillary carcinoma of the thyroid. Hunt JP; Buchmann LO; Wang L; Abraham D Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1141-5. PubMed ID: 22106241 [TBL] [Abstract][Full Text] [Related]
49. Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. Ito Y; Hirokawa M; Jikuzono T; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A World J Surg; 2007 Jun; 31(6):1194-201. PubMed ID: 17431714 [TBL] [Abstract][Full Text] [Related]
50. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. Cappelli C; Castellano M; Braga M; Gandossi E; Pirola I; De Martino E; Agosti B; Rosei EA J Surg Oncol; 2007 Jun; 95(7):555-60. PubMed ID: 17226813 [TBL] [Abstract][Full Text] [Related]
51. Prognostic impact of N staging in 715 medullary thyroid cancer patients: proposal for a revised staging system. Machens A; Dralle H Ann Surg; 2013 Feb; 257(2):323-9. PubMed ID: 22968075 [TBL] [Abstract][Full Text] [Related]
52. Prognostic implications of extranodal extension in papillary thyroid carcinomas: A propensity score matching analysis and proposal for incorporation into current tumor, lymph node, metastasis staging. Genpeng L; Pan Z; Tao W; Rixiang G; Jingqiang Z; Zhihui L; Jianyong L Surgery; 2022 Feb; 171(2):368-376. PubMed ID: 34482990 [TBL] [Abstract][Full Text] [Related]
53. Association of Ultrasound Characteristics With Extranodal Extension in Metastatic Papillary Thyroid Carcinoma. Qualliotine JR; Coquia SF; Hamper UM; Fakhry C JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):263-9. PubMed ID: 26846933 [TBL] [Abstract][Full Text] [Related]
54. Clinical and pathologic features of "sporadic" papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus. Fridman MV; Savva NN; Krasko OV; Zborovskaya AA; Mankovskaya SV; Schmid KW; Demidchik YE Thyroid; 2012 Oct; 22(10):1016-24. PubMed ID: 22947350 [TBL] [Abstract][Full Text] [Related]
55. Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center. Thomas A; Mittal N; Rane SU; Bal M; Patil A; Ankathi SK; Vaish R Head Neck Pathol; 2021 Dec; 15(4):1137-1146. PubMed ID: 33840044 [TBL] [Abstract][Full Text] [Related]
56. Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma. Fan W; Xiao C; Wu F J Int Med Res; 2018 May; 46(5):1982-1989. PubMed ID: 29569965 [TBL] [Abstract][Full Text] [Related]
57. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Roh JL; Kim JM; Park CI Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454 [TBL] [Abstract][Full Text] [Related]
59. The Clinical Relevance of Psammoma Body and Hashimoto Thyroiditis in Papillary Thyroid Carcinoma: A Large Case-control Study. Cai YF; Wang QX; Ni CJ; Guo GL; Li Q; Wang OC; Wu L; Du HY; You J; Zhang XH Medicine (Baltimore); 2015 Nov; 94(44):e1881. PubMed ID: 26554782 [TBL] [Abstract][Full Text] [Related]